This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Paradigm Biopharmaceuticals Ltd. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Alphavirus Treatment by Lara Josefina Herrero
Introduction
Lara Josefina Herrero is an accomplished inventor based in Southport, Australia. She has made significant contributions to the field of medical treatments, particularly in addressing alphavirus-induced inflammation. Her innovative approach has the potential to improve the quality of life for individuals suffering from these infections.
Latest Patents
Lara holds a patent for a method of treating alphavirus infections, specifically focusing on the administration of pentosan polysulfate to infected subjects. This treatment does not affect the viral load but effectively reduces inflammation in tissues, such as muscles and joints. Additionally, it helps mitigate cartilage damage, thereby alleviating the severe pain experienced by patients suffering from infections like Ross River virus, chikungunya virus, and Barmah Forest virus. Her patent represents a significant advancement in therapeutic options for these conditions, with 1 patent to her name.
Career Highlights
Lara is currently associated with Paradigm Biopharmaceuticals Ltd, where she continues to develop and refine her innovative treatments. Her work is characterized by a commitment to improving patient outcomes through scientific research and practical applications of her findings.
Collaborations
Lara collaborates with Surendran Mahalingam, leveraging their combined expertise to enhance the effectiveness of their research and development efforts.
Conclusion
Lara Josefina Herrero's contributions to the treatment of alphavirus infections highlight her dedication to medical innovation. Her work not only addresses critical health issues but also paves the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile